Snapshot
- Page Path
-
- HOME
- ARTICLE CATEGORY
- Snapshot
- Snapshot
- Metabolic dysfunction-associated steatotic liver disease across women’s reproductive lifespan and issues
- Clara Meda, Arianna Dolce, Sara Della Torre
- Clin Mol Hepatol. 2025;31(1):327-332. Published online August 5, 2024
-
View: 722 Download: 73
- Examining the therapeutic landscape of beta-blockers in portal hypertension
- Anna Brujats, Càndid Villanueva
- Clin Mol Hepatol. 2024;30(4):1055-1059. Published online March 6, 2024
-
View: 6152 Download: 70
- Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
- Xinyi Lu, Rui Yang, Yu Chen, Daozhen Chen
- Clin Mol Hepatol. 2024;30(3):582-584. Published online December 29, 2023
-
View: 8581 Download: 100
- Immunopathogenesis of liver fibrosis in steatotic liver disease
- Chaerin Woo, Won-Il Jeong
- Clin Mol Hepatol. 2024;30(2):299-302. Published online February 19, 2024
-
View: 3275 Download: 119
- Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- Young Chang, Soung Won Jeong, Jae Young Jang
- Clin Mol Hepatol. 2024;30(1):129-133. Published online October 13, 2023
-
View: 3621 Download: 173 Crossref: 5
- The role of the hepatic autonomic nervous system
- Qiankun Luo, Pan Liu, Yifei Dong, Tao Qin
- Clin Mol Hepatol. 2023;29(4):1052-1055. Published online July 25, 2023
-
View: 3144 Download: 76
- HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Soon Kyu Lee, Jung Hyun Kwon
- Clin Mol Hepatol. 2023;29(3):825-827. Published online May 31, 2023
-
View: 3766 Download: 105 Web of Science: 1 Crossref: 1
- Systemic therapy in advanced hepatocellular carcinoma
- Joseph C. Ahn, Nguyen H. Tran, Ju Dong Yang
- Clin Mol Hepatol. 2023;29(2):516-519. Published online February 20, 2023
-
View: 4965 Download: 177 Web of Science: 7 Crossref: 8
- Epidemiology and updated management for autoimmune liver disease
- Nae-Yun Heo, Haeryoung Kim
- Clin Mol Hepatol. 2023;29(1):194-196. Published online December 14, 2022
-
View: 5941 Download: 175 Web of Science: 7 Crossref: 9
- Personalized medicine in nonalcoholic fatty liver disease
- Carlos J. Pirola, Silvia Sookoian
- Clin Mol Hepatol. 2022;28(4):935-938. Published online June 24, 2022
-
View: 5424 Download: 155 Web of Science: 8 Crossref: 7
- Microbiome and metabolomics in alcoholic liver disease
- Raja Ganesan, Ki Tae Suk
- Clin Mol Hepatol. 2022;28(3):580-582. Published online July 1, 2022
-
View: 6163 Download: 173 Web of Science: 13 Crossref: 12
- Acute on chronic liver failure in cirrhosis
- Marta Tonon, Salvatore Piano
- Clin Mol Hepatol. 2022;28(2):273-275. Published online February 14, 2022
-
View: 7149 Download: 245 Web of Science: 3 Crossref: 3
- Current status and outcome of liver transplantation in South Korea
- Ho Joong Choi
- Clin Mol Hepatol. 2022;28(1):117-119. Published online December 7, 2021
-
View: 7089 Download: 100 Web of Science: 13 Crossref: 14
- History and future of hepatitis B virus control in South Korea
- Do Young Kim
- Clin Mol Hepatol. 2021;27(4):620-622. Published online September 23, 2021
-
DOI: https://doi.org/10.3350/cmh.2021.0277 Correction in: Clin Mol Hepatol 2022;28(4):939
-
View: 8628 Download: 164 Web of Science: 15 Crossref: 14
- Hepatocellular carcinoma statistics in South Korea
- Young Eun Chon, Soung Won Jeong, Dae Won Jun
- Clin Mol Hepatol. 2021;27(3):512-514. Published online June 21, 2021
-
View: 7614 Download: 188 Web of Science: 35 Crossref: 37
- MODULATION OF LYMPHATIC VESSELS IN MANAGEMENT OF LIVER DISEASE AND COMPLICATIONS
- Aarti Sharma, Pinky Juneja, Shiv K Sarin, Savneet Kaur
- Received September 12, 2024 Accepted October 16, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0793 [Accepted]
-
View: 417 Download: 42
- Interventions Targeting the Gut-Liver Axis: A Potential Treatment Strategy for MASLD
- Pingping Jin, Xinyi Lu, Daozhen Chen, Yu Chen
- Received December 2, 2024 Accepted February 4, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1090 [Accepted]
-
View: 177 Download: 26
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
Video abstract
-
- Metabolic dysfunction-associated steatotic liver disease across women’s reproductive lifespan and issues
- Examining the therapeutic landscape of beta-blockers in portal hypertension
- Immunopathogenesis of liver fibrosis in steatotic liver disease
- Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
- Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- The role of the hepatic autonomic nervous system
- HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
Impact Factor14.0First decision
07 Days
Publication after acceptance
04 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2023-2025)
|
|||||||
